Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations

Movement Disorders

Volumn 19, Issue 5, 2004, Pages 544-548

  Müftüoglu, Meltem ^a   Elibol, Bülent ^a   Dalmizrak, Özlem ^a   Ercan, Ayse ^a   Kulaksiz, Gülnihal ^a   Ögüs, Hamdi ^a   Dalkara, Turgay ^a   Özer, Nazmi ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Complex I; Complex IV; mtDNA; Parkinson's disease

Indexed keywords

MITOCHONDRIAL COMPLEX I; MITOCHONDRIAL COMPLEX IV; MITOCHONDRIAL ENZYME; PARKIN; UNCLASSIFIED DRUG; CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUITIN PROTEIN LIGASE;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; LEUKOCYTE; MITOCHONDRIAL RESPIRATION; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; EXON; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; POINT MUTATION;

ADULT; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX IV; EXONS; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PARKINSON DISEASE; POINT MUTATION; UBIQUITIN-PROTEIN LIGASES;

EID: 4544326057     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10695     Document Type: Article

References (32)

1. Krüger R, Eberhardt O, Riess O, Schulz JB. Parkinson's disease: one biochemical pathway to fit all genes? Trends Mol Med 2002;8:236-240.
2. Vaughan JR, Davis MB, Wood NW. Genetics of parkinsonism: a review. Ann Hum Genet 2001;65:111-126.
3. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608.
4. Tanaka K, Suzuki T, Chiba T, et al. Parkin is linked to the ubiquitin pathway. J Mol Med 2001;79:482-494.
5. Greenamyre JT, Sherer TB, Betarbet R, Panov AV. Complex I and parkinson's disease. IUBMB Life 2001;52:135-141.
6. Andersen JK. What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease? Mech Ageing Dev 2000;118: 15-22.
7. Ataç FB, Elibol B, Hattori N, et al. Molecular analysis of Turkish families with parkin gene mutations. Mov Disord 2000; 15(Suppl.):199.
8. Merlo Pich M, Bovina C, Formiggini G, et al. Inhibitor sensitivity of respiratory complex I in human platelets: a possible biomarker of ageing. FEBS Lett 1996;380:176-178.
9. Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 1996;264:495-496.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193: 265-275.
11. Beutler E. Red cell metabolism, 2nd ed. New York: Grune and Stratton; 1975.
12. Jha N, Jurma O, Lalli G, et al. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. J Biol Chem 2000;275:26096-26101.
13. Bharat S, Cochran BC, Hsu M, et al. Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy. Neurotoxicology 2002;23:479-486.
14. Benecke R, Strümper P, Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkin-plus syndromes. Brain 1993;116:1451-1463.
15. Bindoff LA, Birch Machin MA, Cartlidge NE, et al. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J Neurol Sci 1991;104:203-208.
16. Krige D, Carroll MT, Cooper JM, et al. Platelet mitochondrial function in Parkinson's disease. Ann Neurol 1992;32:782-788.
17. Yoshino H, Hattori Y, Kondo T, Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J Neural Transm 1992;4:27-34.
18. Mizuno Y, Yoshino H, Ikebe S, et al. Mitochondrial dysfunction in Parkinson's Disease. Ann Neurol 1998;44(Suppl.):99-109.
19. Schapira AHV, Gu M, Taanman J, et al. Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann Neurol 1998;44(Suppl.):89-98.
20. Mouradian MM. Recent advances in the genetics and pathogenesis of Parkinson disease. Neurology 2002;58:179-185.
21. Hyun DH, Lee M, Hattori N, et al. Effect of wild-type or mutant parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteosome. J Biol Chem 2002;277:28572-28577.
22. Rajagopalan S, Andersen JK. Alpha synuclein aggregation: is it toxic gain of function responsible for neurodegeneration in Parkinson's disease? Mech Ageing Dev 2001;122:1499-1510.
23. Hashimoto M, Hsu LJ, Rockenstein E, et al. α-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neural cells. J Biol Chem 2002;277:11468-11472.
24. Jha N, Kumar MJ, Boonplueang R, Andersen JK. Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease. J Neurochem 2002;80:555-561.
25. Lee MH, Hyun DH, Jenner P, Halliwell B. Effect of proteosome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J Neurochem 2001;78:32-41.
26. McNaught KS, Belizaire R, Isacson O, et al. Altered proteosomal function in sporadic Parkinson's disease. Exp Neurol 2003;179: 38-46.
27. Zhang Y, Dawson VL, Dawson TM. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis 2000;7:240-250.
28. Benoit I, Lee VM. Parkin and molecular pathways of Parkinson's disease. Neuron 2001;31:885-888.
29. Chung KKK, Dawson VL, Dawson TM. The role of the ubiquitin-proteosomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci 2001;24(Suppl.):7-14.
30. Dagani F, Ferrari R, Anderson JJ, Chase TN. L-dopa does not affect electron transfer chain enzymes and respiration of rat muscle mitochondria. Mov Dis 1991;6:315-319.
31. Haas RH, Nasirian F, Nakano K, et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease. Ann Neurol 1995;37:714-722.
32. Sunada Y, Saito F, Matsumura K, Shimuzu T. Differential expression of the parkin gene in the human brain and peripheral leukocytes. Neurosci Lett 1998;254:180-182.